NCT00621881View on ClinicalTrials.gov

A Phase 1 Study to Compare the PK and Safety of Naproxcinod in Hepatic Impaired Patients and Matching Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

April 30, 2008

Conditions

Liver Disease

Interventions

DRUG

naproxcinod

750 mg bid

Trial Locations (1)

Unknown

Miami

Sponsors

Lead Sponsor

All Listed Sponsors

lead

NicOx

INDUSTRY